139 related articles for article (PubMed ID: 7564242)
21. Comparative study of thymine and uracil metabolism in healthy persons and in a patient with dihydropyrimidine dehydrogenase deficiency.
van Gennip AH; Abeling NG; Elzinga-Zoetekouw L; Scholten LG; van Cruchten A; Bakker HD
Adv Exp Med Biol; 1989; 253A():111-8. PubMed ID: 2624178
[No Abstract] [Full Text] [Related]
22. Identification and tissue-specific expression of a NADH-dependent activity of dihydropyrimidine dehydrogenase in man.
Van Kuilenburg AB; Van Lenthe H; Van Gennip AH
Anticancer Res; 1996; 16(1):389-94. PubMed ID: 8615641
[TBL] [Abstract][Full Text] [Related]
23. [A case of gastric cancer with decreased dihydropyrimidine dehydrogenase activity].
Kobayashi K; Sumi S; Kidouchi K; Mizuno I; Mohri N; Fukui T; Akamo Y; Takeyama H; Manabe T
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1217-9. PubMed ID: 9679586
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the human dihydropyrimidine dehydrogenase gene.
Wei X; Elizondo G; Sapone A; McLeod HL; Raunio H; Fernandez-Salguero P; Gonzalez FJ
Genomics; 1998 Aug; 51(3):391-400. PubMed ID: 9721209
[TBL] [Abstract][Full Text] [Related]
25. Clinical and biochemical abnormalities in a patient with dihydropyrimidine dehydrogenase deficiency due to homozygosity for the C29R mutation.
Van Kuilenburg AB; Vreken P; Riva D; Botteon G; Abeling NG; Bakker HD; Van Gennip AH
J Inherit Metab Dis; 1999 Apr; 22(2):191-2. PubMed ID: 10234617
[No Abstract] [Full Text] [Related]
26. Potential importance of dihydropyrimidine dehydrogenase (DPD) in cancer chemotherapy.
Milano G; Etienne MC
Pharmacogenetics; 1994 Dec; 4(6):301-6. PubMed ID: 7704035
[No Abstract] [Full Text] [Related]
27. New defects of pyrimidine metabolism.
Wadman SK; Beemer FA; de Bree PK; Duran M; van Gennip AH; Ketting D; van Sprang FJ
Adv Exp Med Biol; 1984; 165 Pt A():109-14. PubMed ID: 6720361
[No Abstract] [Full Text] [Related]
28. A pivotal role for beta-aminoisobutyric acid and oxidative stress in dihydropyrimidine dehydrogenase deficiency?
van Kuilenburg AB; Stroomer AE; Abeling NG; van Gennip AH
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1103-6. PubMed ID: 17065072
[TBL] [Abstract][Full Text] [Related]
29. [Dihydropyrimidine dehydrogenase deficiency].
Kouwaki M; Wada Y
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):490-3. PubMed ID: 9590110
[No Abstract] [Full Text] [Related]
30. Identification of novel point mutations in the dihydropyrimidine dehydrogenase gene.
Vreken P; Van Kuilenburg AB; Meinsma R; van Gennip AH
J Inherit Metab Dis; 1997 Jul; 20(3):335-8. PubMed ID: 9266349
[No Abstract] [Full Text] [Related]
31. Defects of pyrimidine degradation: clinical, molecular and diagnostic aspects.
van Gennip AH; van Kuilenburg AB
Adv Exp Med Biol; 2000; 486():233-41. PubMed ID: 11783491
[No Abstract] [Full Text] [Related]
32. Development and characterization of a monoclonal antibody with cross-reactivity towards uracil and thymine, and its potential use in screening patients treated with 5-fluorouracil for possible risks.
Honda T; Inagawa H; Fukushima M; Moriyama A; Soma G
Clin Chim Acta; 2002 Aug; 322(1-2):59-66. PubMed ID: 12104082
[TBL] [Abstract][Full Text] [Related]
33. [Inborn errors of pyrimidine metabolism].
Sumi S; Ito T; Ueta A
Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):412-4. PubMed ID: 11031984
[No Abstract] [Full Text] [Related]
34. Urinary excretion of thymine and uracil in a two-year-old child with a malignant tumor of the brain.
Berglund G; Greter J; Lindstedt S; Steen G; Waldenström J; Wass U
Clin Chem; 1979 Jul; 25(7):1325-8. PubMed ID: 287571
[TBL] [Abstract][Full Text] [Related]
35. Clinical variability in three Danish patients with dihydropyrimidine dehydrogenase deficiency all homozygous for the same mutation.
Christensen E; Cezanne I; Kjaergaard S; Hørlyk H; Faurholt Pedersen V; Vreken P; van Kuilenburg AB; Van Gennip AH
J Inherit Metab Dis; 1998 Jun; 21(3):272-5. PubMed ID: 9686373
[No Abstract] [Full Text] [Related]
36. Assignment of the human dihydropyrimidine dehydrogenase gene (DPYD) to chromosome region 1p22 by fluorescence in situ hybridization.
Takai S; Fernandez-Salguero P; Kimura S; Gonzalez FJ; Yamada K
Genomics; 1994 Dec; 24(3):613-4. PubMed ID: 7713523
[No Abstract] [Full Text] [Related]
37. Inborn errors of pyrimidine degradation: clinical, biochemical and molecular aspects.
van Gennip AH; Abeling NG; Vreken P; van Kuilenburg AB
J Inherit Metab Dis; 1997 Jun; 20(2):203-13. PubMed ID: 9211193
[TBL] [Abstract][Full Text] [Related]
38. Kinetic mechanism of dihydropyrimidine dehydrogenase from pig liver.
Podschun B; Cook PF; Schnackerz KD
J Biol Chem; 1990 Aug; 265(22):12966-72. PubMed ID: 2198281
[TBL] [Abstract][Full Text] [Related]
39. Clinical and biochemical aspects of dihydropyrimidinase deficiency.
Van Gennip AH; De Abreu RA; Vreken P; Van Kuilenburg AB
Adv Exp Med Biol; 1998; 431():125-8. PubMed ID: 9598044
[No Abstract] [Full Text] [Related]
40. A screening method for dihydropyrimidine dehydrogenase deficiency with colorimetric detection of urinary uracil.
Okajima K; Yamamoto T; Suchi M; Wada Y
Adv Exp Med Biol; 1989; 253A():119-22. PubMed ID: 2624179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
